FDA Drug Approvals Don't Include Impurities, DC Circ. Rules
By Dorothy Atkins · January 10, 2023, 7:36 PM EST
The D.C. Circuit affirmed Tuesday the U.S. Food and Drug Administration's win in Sandoz Inc.'s lawsuit challenging the agency's decision to give rival Sanofi exclusivity to its multiple sclerosis drug, Aubagio,...
To view the full article, register now.